Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 20.07. ACNE | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Skin Keratolytics | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Skin Keratolytics | No observations |
| Haiti. National List of Essential Medicines | 13.04. Keratoplastics/ Keratolytics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 13.4. Medicines affecting skin differentiation and proliferation | No observations |
| Belize. National Drug Formulary | 13.05 Medicines affecting skin differentiation and proliferation | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | D. MEDICAMENTOS DERMATOLÓGICOS | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | D. MEDICAMENTOS DERMATOLÓGICOS | No observations |
| List | Section | Observation |
|---|---|---|
| Bahamas. Drug Formulary | 17.4. Keratolytics/Caustics and Antiacne Agents | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 13.4 Medications that Affect Differentiation and Proliferation of Skin | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Skin Keratolytics | No observations |
| Bahamas. Drug Formulary | 17.4. Keratolytics/Caustics and Antiacne Agents | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | Topical Preparations | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Skin Keratolytics | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 46. Preparaciones dermatológicas | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Acne | No observations |
| Suriname. NGK-C-011 | 13.4 Agents acting on the differentiation and proliferation of the skin | No observations |
| Bahamas. Drug Formulary | 17.4. Keratolytics/Caustics and Antiacne Agents | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | Topical Preparations | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 13.4. Medicines affecting skin differentiation and proliferation | No observations |
| Belize. National Drug Formulary | 13.05 Medicines affecting skin differentiation and proliferation | No observations |
| List | Section | Observation |
|---|---|---|
| Bahamas. Drug Formulary | 17.4. Keratolytics/Caustics and Antiacne Agents | No observations |
| List | Section | Observation |
|---|---|---|
| Bahamas. Drug Formulary | 17.4. Keratolytics/Caustics and Antiacne Agents | No observations |
| List | Section | Observation |
|---|---|---|
| Bahamas. Drug Formulary | 17.4. Keratolytics/Caustics and Antiacne Agents | No observations |